Safety and immunogenicity of VGX-3100 formulations in a healthy young adult population

• প্রধান লেখক: Rebecca K. Hollenberg (লেখক), Diane R. Krieger (লেখক), Robert Samuels (লেখক), Kim Kraynyak (লেখক), Albert Sylvester (লেখক), Matthew Morrow (লেখক), Jean Boyer (লেখক), Michael Dallas (লেখক), Prakash K. Bhuyan (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Taylor & Francis Group, 2020-06-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

HPV remains the most common sexually transmitted disease worldwide, despite improvements in awareness, screening, prophylactic vaccination uptake, and surgical treatment. VGX-3100 is an immunotherapy that uses electroporation to introduce DNA encoding for modified HPV-16 and HPV-18, E6-and E7 protei...